agilon health (NYSE:AGL) Issues Quarterly Earnings Results

agilon health (NYSE:AGL) posted its quarterly earnings results on Tuesday. The company reported ($0.07) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.07), Briefing.com reports. The business had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative net margin of 5.67% and a negative return on equity of 26.15%. The company’s revenue was up 38.7% on a year-over-year basis. During the same period in the prior year, the business posted ($0.04) earnings per share. agilon health updated its Q3 2024 guidance to EPS and its FY 2024 guidance to EPS.

agilon health Trading Down 9.2 %

Shares of AGL stock traded down $0.58 during trading hours on Wednesday, reaching $5.65. 5,834,350 shares of the stock were exchanged, compared to its average volume of 5,150,248. The firm has a market capitalization of $2.32 billion, a price-to-earnings ratio of -8.06 and a beta of 0.60. agilon health has a 12-month low of $4.41 and a 12-month high of $20.37. The company’s 50-day moving average price is $6.54 and its 200-day moving average price is $6.00. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.04.

Analysts Set New Price Targets

A number of research firms recently weighed in on AGL. Evercore ISI lifted their target price on shares of agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a research note on Tuesday, July 9th. Stifel Nicolaus lowered their price objective on agilon health from $8.00 to $7.00 and set a “hold” rating on the stock in a research report on Wednesday, May 1st. Robert W. Baird assumed coverage on agilon health in a research report on Thursday, May 30th. They set a “neutral” rating and a $6.00 target price for the company. Citigroup assumed coverage on agilon health in a report on Monday, April 22nd. They issued a “neutral” rating and a $6.00 price target on the stock. Finally, Baird R W raised shares of agilon health to a “hold” rating in a report on Thursday, May 30th. One research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $9.10.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.